Rubinstein-Taybi syndrome due to CREBBP mutations: genes and variants

Explore variant evidence for Rubinstein-Taybi syndrome due to CREBBP mutations across 2 analyzed proteins (CREBBP, EP300). Linked ClinVar records include 53 pathogenic or likely pathogenic variants, 175 variants of uncertain significance and 80 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Rubinstein-Taybi syndrome due to CREBBP mutations

Where Rubinstein-Taybi syndrome due to CREBBP mutations variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Rubinstein-Taybi syndrome due to CREBBP mutations

VariantPositionProtein partClinical label
CREBBP R1378P1378CBP/p300-type HATPathogenic / likely pathogenic (★★)
CREBBP E1278K1278Pathogenic / likely pathogenic (★★)
CREBBP R1378Q1378CBP/p300-type HATPathogenic / likely pathogenic (★★)
CREBBP T1426R1426CBP/p300-type HATPathogenic / likely pathogenic (★★)
CREBBP D1480G1480CBP/p300-type HATPathogenic / likely pathogenic (★★)
CREBBP R1664H1664CBP/p300-type HATPathogenic / likely pathogenic (★★)
CREBBP A1782V1782TAZ-type 2Pathogenic / likely pathogenic (★★)
CREBBP R601W601KIXPathogenic / likely pathogenic (★★)
CREBBP L608P608KIXPathogenic / likely pathogenic (★★)
CREBBP Y1175C1175BromoPathogenic / likely pathogenic (★★)
CREBBP C1240Y1240Pathogenic / likely pathogenic (★★)
CREBBP S1687F1687CBP/p300-type HATPathogenic / likely pathogenic (★★)
CREBBP C1720R1720ZZ-typePathogenic / likely pathogenic (★★)
CREBBP C1723W1723ZZ-typePathogenic / likely pathogenic (★★)
CREBBP L1779P1779TAZ-type 2Pathogenic / likely pathogenic (★★)
CREBBP R1786H1786TAZ-type 2Pathogenic / likely pathogenic (★★)
CREBBP D1435E1435CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP Y1482C1482CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP Y1482D1482CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP R1446H1446CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP Q1491K1491CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP E1278Q1278Pathogenic / likely pathogenic (★)
CREBBP R1427S1427CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP Y1503C1503CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP Y1503F1503CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP R1664L1664CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP G1746V1746ZZ-typePathogenic / likely pathogenic (★)
CREBBP M1K1Pathogenic / likely pathogenic (★)
CREBBP K13E13Pathogenic / likely pathogenic (★)
CREBBP H365P365TAZ-type 1Pathogenic / likely pathogenic (★)
CREBBP A644P644KIXPathogenic / likely pathogenic (★)
CREBBP A1164P1164BromoPathogenic / likely pathogenic (★)
CREBBP T1171R1171BromoPathogenic / likely pathogenic (★)
CREBBP R1341P1341CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP V1361A1361CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP V1371D1371CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP P1373H1373CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP F1409S1409CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP C1421F1421CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP E1459G1459CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP S1684P1684CBP/p300-type HATPathogenic / likely pathogenic (★)
CREBBP C1729S1729ZZ-typePathogenic / likely pathogenic (★)
CREBBP H1804Q1804TAZ-type 2Pathogenic / likely pathogenic (★)
EP300 C1250Y1250Pathogenic / likely pathogenic (★)
CREBBP D1435Y1435CBP/p300-type HATPathogenic / likely pathogenic
CREBBP R1428P1428CBP/p300-type HATPathogenic / likely pathogenic
CREBBP Y1433H1433CBP/p300-type HATPathogenic / likely pathogenic
CREBBP R1347P1347CBP/p300-type HATPathogenic / likely pathogenic
CREBBP S1382F1382CBP/p300-type HATPathogenic / likely pathogenic
CREBBP R1392L1392CBP/p300-type HATPathogenic / likely pathogenic
CREBBP A1473T1473CBP/p300-type HATPathogenic / likely pathogenic
CREBBP H1487R1487CBP/p300-type HATPathogenic / likely pathogenic
CREBBP S1179G1179BromoPathogenic / likely pathogenic

Uncertain variants prioritized for review in Rubinstein-Taybi syndrome due to CREBBP mutations

VariantPositionProtein partClinical labelEvidence
CREBBP R1378W1378CBP/p300-type HATUncertain (★)+7: 2 other pathogenic changes within 3 positions; R1378P at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.812

Which prediction tools work for Rubinstein-Taybi syndrome due to CREBBP mutations

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Rubinstein-Taybi syndrome due to CREBBP mutations

Frequently asked questions

Which genes have records linked to Rubinstein-Taybi syndrome due to CREBBP mutations?

This view contains 2 analyzed proteins: CREBBP, EP300. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 53 pathogenic or likely pathogenic variants, 175 variants of uncertain significance and 80 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 400 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center